


















































































































































































































































































































































































































































































































































































































































































































Aim		 Study	methods	 Population	 Integrated	care	
model	
within	HIV	clinical	
care		
implementatio
n	of	new	
services		
community	or	HIV	
care	centres		
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Table	2.	Expert	experiences	and	policy	literature	
Citation		 Country	 Report	aim	or	
focus		
Report	
design	or	
approach	
Population	 Integrated	
care	model	
1	Ambekar,		
et	al.	(2014).		
India		 Survey	of	
experiences	of	
PWUD	in	drug	
use	and	service	
access	
Structured	
interviews	
with	PWUD	
1000	PWUD	
across	22	sites	
Context	for	
survey	of	
‘Targeted	
Interventions’	
for	PWUD;	
centres	that	
include	OST,	
NSP	and	link	
to	HIV	care	
2	Bruce,	et	
al.	2014		
Tanzania		 Reflections	on	
lessons	learned	
through	
implementing	
integrated	OST	
and	HIV	care	
No	particular	
design;	
report	by	
programme	
team		
12	member	
team	engaged	
in	delivery	or	
development	
of	the	services		
MAT	site	in	
Tanzania,	with	
integrated	HIV	
care:	ART	daily	
dosing	
alongside	
observed	MAT	
3	Curtis.	
(2009).		
Ukraine	 WHO	
commissioned	
short	report	of	
case	studies	of	
integration		
No	particular	
design;	
author	led	
consultation	
and	
observations		
Various	
providers	and	
service	clients	
across	
multiple	
Various	sites	in	
Ukraine:	one	
site	of	
referrals	
between	
clinics;	MAT	
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Citation		 Country	 Report	aim	or	
focus		
Report	
design	or	
approach	
Population	 Integrated	
care	model	
service	sites	(n	
not	specified).	
site	in	a	
hospital	linked	
to	other	
clinics;	co-
location	of	
services	within	
an	HIV	focused	
site		
4	
Demchenko,	
et	al.	(2014).		
Ukraine		 Evaluation	of	
service	access	
for	PWUD	
Semi-
structured	
interviews	
and	focus	
groups	with	
clients,	in-
depth	
interviews	
with	
providers	
500	clients	of	
OST	
Various	sites	in	
Ukraine	
5	Grenfell	et	
al	(2012)		
Portugal	 Rapid	
assessment	to	
assess	
acceptability	and	
integration	of	
Mixed-
methods	
rapid	
assessment	
including	
30	PWID	(3	
women,	27	
men;	26	
PLHIV,	and	21	
currently	on	
Two	models	
documented:	
i)	all	services	
available	
within	a	single	
	23	
	
Citation		 Country	 Report	aim	or	
focus		
Report	
design	or	
approach	
Population	 Integrated	
care	model	
HIV,	TB	and	drug	
dependency	
treatment	
(including	OST)	
in	Portugal	
mapping,	
analysis	of	
secondary	
data	and	
interviews	
with	PWID	
and	providers	
treatment;	26	
had	
experienced	
OST,	24	
currently)		
7	providers	
engaged	in	
HIV,	TB	and	
OST	care	
centre,	ii)	
services	
available	
through	
referral	
between	
separate	
facilities,	
supported	by	
outreach	
teams		
6	Van	Laere,	
et	al.	(2010).		
Indonesia	 Baseline	
evaluation	of	
services	in	six	
methadone	
clinics		
Mixed	
methods	
evaluation,	
including	
interviews	
with	
providers,	
and	focus	
groups		
Providers,	n	
not	stated		
MAT	clinics	
with	varying	
levels	of	on-
site	
integration	of	
HIV	care:	HIV	
prevention	
(condoms,	
NSP),	VCT.	ART	
only	by	
referral	to	HIV	
clinics.	
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Citation		 Country	 Report	aim	or	
focus		
Report	
design	or	
approach	
Population	 Integrated	
care	model	
7	Tobias,	et	
al.	(2000).		
USA	 Information	
review	on	
delivery	of	HIV	
services	for	
people	using	
drugs		
Literature	
review	and	
key	
informant	
interviews		
50	key	
informants	
(providers,	
community	
leaders,	
government	
staff,	
researchers)	
Not	applicable	
8	Pangaea	
Global	AIDS	
Foundation.	
2014		
Global		 Expert	
consultation	on	
appropriate	
models	of	
integrated	HIV	
care	for	PWID	in	
Africa		
Expert	
perspectives	
and	reports	
on	
programme	
experience		
Stakeholders,	
including	
providers	
Various		
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Table	3.	Summary	of	review	findings	and	CERQUAL	assessment		
Theme	 Included	citations		 CERQual	
assessment	of	
confidence	in	the	
evidence	
Explanation	of	
CERQual	
assessment	
1	Convenient	and	comprehensive	OST	and	HIV	care	
through	co-located	integrated	care	
Having	OST	and	HIV	care	available	at	one	site,	whether	
through	a	single	provider	or	team	of	providers,	was	
welcomed	by	clients	as	convenient	and	facilitating	
attention	to	multiple	health	priorities.	There	are	still	
limitations	described,	with	access	to	a	single	facility	
itself	posing	challenges	of	time	and	transport.	
Drainoni	et	al	2014,	
Egan	et	al	2011,	
Korthuis	et	al	2010,	
Lin	et	al	2014,	
Morrow	&	Costello	
2004,	Weiss	et	al	
2011	
High/moderate	
High	
methodology	
quality,	high	
relevance,	and	
high	coherence,	
although	thin	
data	and	narrow	
range	of	
countries	
represented.	
2	Contrasting	philosophies	of	care	Integrated	care	
varied	according	to	different	philosophies,	centred	on	
harm	reduction	or	sobriety,	with	clients	having	
different	preferences	shaped	by	their	experiences	and	
goals	for	OST.	
Drainoni	et	al	2014,	
Egan	et	al	2011,	
Korthuis	et	al	2010,	
Strauss	&	Mino	2011,	
Weiss	et	al	2011	
moderate	
High	relevance,	
but	only	
moderate	
methodological	
quality	and	
coherence,	with	
low	range	of	
countries.	
3	The	challenges	of	discussing	and	disclosing	HIV	and	
drug	use	Whilst	some	reported	comfort	and	willingness	
to	disclosure	and	discuss	HIV	status,	some	found	this	
difficult	because	of	stigma	and	fears	of	discrimination,	
or	not	considering	it	necessary	to	address	HIV	in	OST	
settings	
Batchelder	et	al	
2013,	Drainoni	et	al	
2014,	Egan	et	al	
2011,	Korthuis	et	al	
2010,	Lin	et	al	2014	
moderate	
High	relevance,	
but	moderate	
quality,	and	low	
coherence	and	
range	of	
countries		
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4	OST	enabling	HIV	treatment	OST	facilitates	
overcoming	social	and	structural	barriers	to	addressing	
HIV	for	some	people,	through	varying	mechanisms	
Egan	et	al	2011,	
Korthuis	et	al	2010,	
Mimiaga	et	al	2010,	
Sarang	et	al	2013,	
Weiss	et	al	2011	
low	
Moderate	quality	
and	relevance,	
but	low	
coherence	and	
low	range	of	
countries	
5	The	health	system	context	for	integrated	care	
Contextual	policy	and	system	issues	shape	the	potential	
for,	and	nature	of,	integration	
Chakrapani	et	al	
2014,	Drainoni	et	al	
2014,	Lin	et	al	2014,	
Strauss	&	Mino	2011,	
Weiss	et	al	2011	
Moderate/low	
High	relevance,	
but	moderate	
quality	and	low	
coherence	and	
adequacy	
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